The document announces the 2017 Annual Meeting to take place October 25-26, 2017 in Boston, Massachusetts. It will feature opportunities in personalized medicine with speakers from Digital Science, TriLink Biotechnologies, and New England Biolabs. There are also links to YouTube videos about the annual meeting from July 2017. The document discusses funding trends for CAR T-cell and CRISPR research over time, with international funders like Germany, the EU, and China playing a growing role in recent years building upon the foundational work by Dr. Carl June and the NCI in the early 2000s. Current funding and publication trends indicate CAR research remains small compared to leukemia research overall, while new interest in CRISPR provides more